Assessment of Naples prognostic score in predicting survival for small cell lung cancer patients treated with chemoradiotherapy

References

• Dingemans AC, Fruh M, Ardizzoni A, et al. Small-cell lung cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2021;32(7):1–11. doi: 10.1016/j.annonc.2021.03.207.
   Web of Science ®Google Scholar
• Sen T, Gay CM, Byers LA. Targeting DNA damage repair in small cell lung cancer and the biomarker landscape. Transl Lung Cancer Res. 2018;7(1):50–68. doi: 10.21037/tlcr.2018.02.03.
   PubMed Web of Science ®Google Scholar
• Alvarado-Luna G, Morales-Espinosa D. Treatment for small cell lung cancer, where are we now?-a review. Transl Lung Cancer Res. 2016;5(1):26–38.
   PubMed Web of Science ®Google Scholar
• Guo D, Jing W, Zhu H, et al. Clinical value of carcinoembryonic antigen for predicting the incidence of brain metastases and survival in small cell lung cancer patients treated with prophylactic cranial irradiation. Cancer Manag Res. 2018;10:3199–3205. doi: 10.2147/CMAR.S175043.
   PubMed Web of Science ®Google Scholar
• Stratigos M, Matikas A, Voutsina A, et al. Targeting angiogenesis in small cell lung cancer. Transl Lung Cancer Res. 2016;5(4):389–400. doi: 10.21037/tlcr.2016.08.04.
   PubMed Web of Science ®Google Scholar
• Tsoukalas N, Aravantinou-Fatorou E, Baxevanos P, et al. Advanced small cell lung cancer (SCLC): new challenges and new expectations. Ann Transl Med. 2018;6(8):145. doi: 10.21037/atm.2018.03.31.
   PubMed Web of Science ®Google Scholar
• Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011;144(5):646–674. doi: 10.1016/j.cell.2011.02.013.
   PubMed Web of Science ®Google Scholar
• Mantovani A, Allavena P, Sica A, et al. Cancer-related inflammation. Nature. 2008;454(7203):436–444. doi: 10.1038/nature07205.
   PubMed Web of Science ®Google Scholar
• Feng JF, Huang Y, Chen QX. Preoperative platelet lymphocyte ratio (PLR) is superior to neutrophil lymphocyte ratio (NLR) as a predictive factor in patients with esophageal squamous cell carcinoma. World J Surg Oncol. 2014;12:58. doi: 10.1186/1477-7819-12-58.
   PubMed Web of Science ®Google Scholar
• Guo D, Jin F, Jing W, et al. Incorporation of the SUVmax measured from FDG PET and neutrophil-to-lymphocyte ratio improves prediction of clinical outcomes in patients with locally advanced non-small-cell lung cancer. Clin Lung Cancer. 2019;20(6):412–419. doi: 10.1016/j.cllc.2019.06.008.
   PubMed Web of Science ®Google Scholar
• Guo D, Zhang J, Jing W, et al. Prognostic value of systemic immune-inflammation index in patients with advanced non-small-cell lung cancer. Future Oncol. 2018;14(25):2643–2650. doi: 10.2217/fon-2018-0285.
   PubMed Web of Science ®Google Scholar
• Li KJ, Xia XF, Su M, et al. Predictive value of lymphocyte-to-monocyte ratio (LMR) and neutrophil-to-lymphocyte ratio (NLR) in patients with oesophageal cancer undergoing concurrent chemoradiotherapy. BMC Cancer. 2019;19(1):1004. doi: 10.1186/s12885-019-6157-4.
   PubMed Web of Science ®Google Scholar
• Liu Z, Shi H, Chen L. Prognostic role of pre-treatment C-reactive protein/albumin ratio in esophageal cancer: a meta-analysis. BMC Cancer. 2019;19(1):1161. doi: 10.1186/s12885-019-6373-y.
   PubMed Web of Science ®Google Scholar
• Harimoto N, Yoshizumi T, Inokuchi S, et al. Prognostic significance of preoperative controlling nutritional status (CONUT) score in patients undergoing hepatic resection for hepatocellular carcinoma: a multi-institutional study. Ann Surg Oncol. 2018;25(11):3316–3323. doi: 10.1245/s10434-018-6672-6.
   PubMed Web of Science ®Google Scholar
• Sonehara K, Tateishi K, Komatsu M, et al. Modified glasgow prognostic score as a prognostic factor in patients with extensive disease-small-cell lung cancer: a retrospective study in a single institute. Chemotherapy. 2019;64(3):129–137. doi: 10.1159/000502681.
   PubMed Web of Science ®Google Scholar
• Yang Y, Gao P, Song Y, et al. The prognostic nutritional index is a predictive indicator of prognosis and postoperative complications in gastric cancer: a meta-analysis. Eur J Surg Oncol. 2016;42(8):1176–1182. doi: 10.1016/j.ejso.2016.05.029.
   PubMed Web of Science ®Google Scholar
• Galizia G, Auricchio A, de Vita F, et al. Inflammatory and nutritional status is a predictor of long-term outcome in patients undergoing surgery for gastric cancer. Validation of the Naples prognostic score. Ann Ital Chir. 2019;90:404–416.
   PubMed Web of Science ®Google Scholar
• Kano K, Yamada T, Yamamoto K, et al. The impact of pretherapeutic Naples prognostic score on survival in patients with locally advanced esophageal cancer. Ann Surg Oncol. 2021;28(8):4530–4539. doi: 10.1245/s10434-020-09549-5.
   PubMed Web of Science ®Google Scholar
• Nakagawa N, Yamada S, Sonohara F, et al. Clinical implications of Naples prognostic score in patients with resected pancreatic cancer. Ann Surg Oncol. 2020;27(3):887–895. doi: 10.1245/s10434-019-08047-7.
   PubMed Web of Science ®Google Scholar
• Miyamoto Y, Hiyoshi Y, Daitoku N, et al. Naples prognostic score is a useful prognostic marker in patients with metastatic colorectal cancer. Dis Colon Rectum. 2019;62(12):1485–1493. doi: 10.1097/DCR.0000000000001484.
   PubMed Web of Science ®Google Scholar
• Galizia G, Lieto E, Auricchio A, et al. Naples prognostic score, based on nutritional and inflammatory status, is an independent predictor of long-term outcome in patients undergoing surgery for colorectal cancer. Dis Colon Rectum. 2017;60(12):1273–1284. doi: 10.1097/DCR.0000000000000961.
   PubMed Web of Science ®Google Scholar
• Li A, He K, Guo D, et al. Pretreatment blood biomarkers predict pathologic responses to neo-CRT in patients with locally advanced rectal cancer. Future Oncol. 2019;15(28):3233–3242. doi: 10.2217/fon-2019-0389.
   PubMed Web of Science ®Google Scholar
• Balkwill F, Mantovani A. Inflammation and cancer: back to Virchow? Lancet. 2001;357(9255):539–545. doi: 10.1016/S0140-6736(00)04046-0.
   PubMed Web of Science ®Google Scholar
• Apte RS, Chen DS, Ferrara N. VEGF in signaling and disease: beyond discovery and development. Cell. 2019;176(6):1248–1264. doi: 10.1016/j.cell.2019.01.021.
   PubMed Web of Science ®Google Scholar
• Centurione L, Aiello FB. DNA repair and cytokines: TGF-beta, IL-6, and thrombopoietin as different biomarkers of radioresistance. Front Oncol. 2016;6:175. doi: 10.3389/fonc.2016.00175.
   PubMed Web of Science ®Google Scholar
• Grivennikov SI, Greten FR, Karin M. Immunity, inflammation, and cancer. Cell. 2010;140(6):883–899. doi: 10.1016/j.cell.2010.01.025.
   PubMed Web of Science ®Google Scholar
• Shaverdian N, Wang J, Levin-Epstein R, et al. Pro-inflammatory state portends poor outcomes with stereotactic radiosurgery for brain metastases. Anticancer Res. 2016;36(10):5333–5337. doi: 10.21873/anticanres.11106.
   PubMed Web of Science ®Google Scholar
• Wu L, Saxena S, Awaji M, et al. Tumor-Associated neutrophils in cancer: going pro. Cancers (Basel). 2019;11(4):564. doi: 10.3390/cancers11040564.
   Web of Science ®Google Scholar
• Houghton AM, Rzymkiewicz DM, Ji H, et al. Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med. 2010;16(2):219–223. doi: 10.1038/nm.2084.
   PubMed Web of Science ®Google Scholar
• Lerman I, Hammes SR. Neutrophil elastase in the tumor microenvironment. Steroids. 2018;133:96–101. doi: 10.1016/j.steroids.2017.11.006.
   PubMed Web of Science ®Google Scholar
• Laviron M, Combadiere C, Boissonnas A. Tracking monocytes and macrophages in tumors with live imaging. Front Immunol. 2019;10:1201. doi: 10.3389/fimmu.2019.01201.
   PubMed Web of Science ®Google Scholar
• Ronca R, Benkheil M, Mitola S, et al. Tumor angiogenesis revisited: regulators and clinical implications. Med Res Rev. 2017;37(6):1231–1274. doi: 10.1002/med.21452.
   PubMed Web of Science ®Google Scholar
• Droin N, Hendra JB, Ducoroy P, et al. Human defensins as cancer biomarkers and antitumour molecules. J Proteomics. 2009;72(6):918–927. doi: 10.1016/j.jprot.2009.01.002.
   PubMed Web of Science ®Google Scholar
• Goedegebuure RSA, Harrasser M, de Klerk LK, et al. Pre-treatment tumor-infiltrating T cells influence response to neoadjuvant chemoradiotherapy in esophageal adenocarcinoma. Oncoimmunology. 2021;10(1):1954807. doi: 10.1080/2162402X.2021.1954807.
   PubMed Web of Science ®Google Scholar
• Mohammed ZM, Going JJ, Edwards J, et al. The role of the tumour inflammatory cell infiltrate in predicting recurrence and survival in patients with primary operable breast cancer. Cancer Treat Rev. 2012;38(8):943–955. doi: 10.1016/j.ctrv.2012.04.011.
   PubMed Web of Science ®Google Scholar
• Guo W, Lu X, Liu Q, et al. Prognostic value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio for breast cancer patients: an updated meta-analysis of 17079 individuals. Cancer Med. 2019;8(9):4135–4148. doi: 10.1002/cam4.2281.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Feng YC, Zhu HG, et al. The peripheral blood neutrophil-to-lymphocyte ratio is a prognostic predictor for survival of EGFR-mutant nonsmall cell lung cancer patients treated with EGFR-TKIs. Medicine (Baltimore). 2018;97(30):e11648. doi: 10.1097/MD.0000000000011648.
   PubMed Web of Science ®Google Scholar
• Go SI, Kim RB, Song HN, et al. Prognostic significance of the lymphocyte-to-monocyte ratio in patients with small cell lung cancer. Med Oncol. 2014;31(12):323. doi: 10.1007/s12032-014-0323-y.
   PubMed Web of Science ®Google Scholar
• Ramos R, Macia I, Navarro-Martin A, et al. Prognostic value of the preoperative lymphocyte-to-monocyte ratio for survival after lung cancer surgery. BMC Pulm Med. 2021;21(1):75. doi: 10.1186/s12890-021-01446-1.
   PubMed Web of Science ®Google Scholar
• Huang X, Hu H, Zhang W, et al. Prognostic value of prognostic nutritional index and systemic immune-inflammation index in patients with osteosarcoma. J Cell Physiol. 2019;234(10):18408–18414. doi: 10.1002/jcp.28476.
   PubMed Web of Science ®Google Scholar
• Tokunaga R, Sakamoto Y, Nakagawa S, et al. CONUT: a novel independent predictive score for colorectal cancer patients undergoing potentially curative resection. Int J Colorectal Dis. 2017;32(1):99–106. doi: 10.1007/s00384-016-2668-5.
   PubMed Web of Science ®Google Scholar
• Oliver MF. Serum cholesterol–the knave of hearts and the joker. Lancet. 1981;2(8255):1090–1095. doi: 10.1016/s0140-6736(81)91286-1.
   PubMed Web of Science ®Google Scholar
• Jin Y, Zhao L, Peng F. Prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancer. Clinics (Sao Paulo). 2013;68(5):686–693. doi: 10.6061/clinics/2013(05)17.
   PubMed Web of Science ®Google Scholar
• Lei J, Wang Y, Guo X, et al. Low preoperative serum ALB level is independently associated with poor overall survival in endometrial cancer patients. Future Oncol. 2020;16(8):307–316. doi: 10.2217/fon-2019-0732.
   PubMed Web of Science ®Google Scholar
• Mandal CC, Rahman MM. Targeting intracellular cholesterol is a novel therapeutic strategy for cancer treatment. J Cancer Sci Ther. 2014;6(12):510–513. doi: 10.4172/1948-5956.1000316.
   PubMedGoogle Scholar
• Kang R, Li P, Wang T, et al. Apolipoprotein E epsilon 2 allele and low serum cholesterol as risk factors for gastric cancer in a Chinese Han population. Sci Rep. 2016;6:19930. doi: 10.1038/srep19930.
   PubMed Web of Science ®Google Scholar
• Li Q, Cong R, Wang Y, et al. Naples prognostic score is an independent prognostic factor in patients with operable endometrial cancer: results from a retrospective cohort study. Gynecol Oncol. 2021;160(1):91–98. doi: 10.1016/j.ygyno.2020.10.013.
   PubMed Web of Science ®Google Scholar
• Li S, Wang H, Yang Z, et al. Naples prognostic score as a novel prognostic prediction tool in video-assisted thoracoscopic surgery for early-stage lung cancer: a propensity score matching study. Surg Endosc. 2021;35(7):3679–3697. doi: 10.1007/s00464-020-07851-7.
   PubMed Web of Science ®Google Scholar
• Yang Q, Chen T, Yao Z, et al. Prognostic value of pre-treatment Naples prognostic score (NPS) in patients with osteosarcoma. World J Surg Oncol. 2020;18(1):24. doi: 10.1186/s12957-020-1789-z.
   PubMed Web of Science ®Google Scholar
• Lieto E, Auricchio A, Tirino G, et al. Naples prognostic score predicts tumor regression grade in resectable gastric cancer treated with preoperative chemotherapy. Cancers (Basel). 2021;13(18):4676. doi: 10.3390/cancers13184676.
   PubMed Web of Science ®Google Scholar